Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 33, Issue 2, 2005, Pages 101-111

  Wakamoto, Shinobu ^a   Fujihara, Mitsuhiro ^a   Abe, Hideki ^a   Yamaguchi, Miki ^a   Azuma, Hiroshi ^a   Ikeda, Hisami ^a   Takeoka, Shinji ^b   Tsuchida, Eishun ^b  

^a JAPANESE RED CROSS SOCIETY   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BIOLOGICAL MEMBRANES; BIOMEDICAL ENGINEERING; CELLS; HEMOGLOBIN; OXYGEN; PHOSPHOLIPIDS;

HEMOGLOBIN VESICLES (HBV); HUMAN BLOOD CELLS; PLATELET RICH PLASMA; PREINCUBATION;

BLOOD;

1,5 DIPALMITOYLGLUTAMATE N SUCCINIC ACID; ADENOSINE DIPHOSPHATE; BETA THROMBOGLOBULIN; CARBOXYHEMOGLOBIN; CHOLESTEROL; COLLAGEN; DIPALMITOYLPHOSPHATIDYLCHOLINE; FIBRINOGEN RECEPTOR; HOMOCYSTEINE; L SELECTIN; LIPOSOME; MACROGOL DERIVATIVE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PAC 1; PHOSPHOLIPID; POLYETHYLENE GLYCOL 1,2 DISTEARYLGLYCERO 3 PHOSPHATIDYLETHANOLAMINE; PYRIDOXAL 5 PHOSPHATE; RANTES; SEROTONIN; THROMBOXANE B2; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BLOOD SUBSTITUTION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMORRHAGIC SHOCK; HUMAN; HUMAN CELL; IN VITRO STUDY; OXYGEN TRANSPORT; PHOSPHOLIPID BILAYER; SEROTONIN RELEASE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA;

BIOLOGICAL MARKERS; BLOOD PLATELETS; DRUG DELIVERY SYSTEMS; HEMOGLOBINS; HUMANS; INFLAMMATION; LIPOSOMES; P-SELECTIN; PHOSPHOLIPIDS; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RANTES; THROMBOPHILIA; THROMBOXANE B2;

RODENTIA;

EID: 20044374204     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIO-200055856     Document Type: Article

References (27)

1. Chang, T.M.S. (2000). Is there a need for blood substitutes in the new millennium and what should we expect in the way of safety and efficacy? Art. Cells, Blood Subs., and Immob. Biotech. 28: v-xi.
2. Johnson, J.L., Moore, E.E., Offner, P.J., Haenel, J.B., Hides, G.A., Tamura, D.Y. (1998). Resuscitation of the injured patient with polymerized stroma-free hemoglobin does not produce systemic or pulmonary hypertension. Am. J. Surg. 176: 612-617.
3. Mullon, J., Giacoppe, G., Clagett, C., McCune, D., Dillard, T. (2000). Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. N. Engl. J. Med. 342: 1638-1643.
4. Carmichael, F.J., Ali, A.C., Campbell, J.A., Langlois, S.F., Biro, G.P., Willan, A.R., Pierce, C.H., Greenburg, A.G. (2000). A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit. Care Med. 28: 2283-2292.
5. Sakai, H., Tomiyama, K.I., Sou, K., Takeoka, S., Tsuchida, E. (2000). Poly (ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. Bioconjug. Chem. 11: 425-432.
6. Tsuchida, E., Takeoka, S. (1995). Stabilized hemoglobin vesicles, in Artificial Red Cells: Materials, Performances and Clinical Study as Blood Substitutes, E. Tsuchida, Ed., John Wiley and Sons: Chichester, pp. 35-64.
7. Izumi, Y., Sakai, H., Kose, T., Hamada, K., Takeoka, S., Yoshizu, A., Horinouchi, H., Kato, R., Nishide, H., Tsuchida, E., Kobayashi, K. (1997). Evaluation of the capabilities of a hemoglobin vesicle as an artificial oxygen carrier in a rat exchange transfusion model. ASAIO J. 43: 289-297.
8. Izumi, Y., Sakai, H., Hamada, K., Takeoka, S., Yamahata, T., Kato, R., Nishide, H., Tsuchida, E., Kobayashi, K. (1996). Physiologic responses to exchange transfusion with hemoglobin vesicles as an artificial oxygen carrier in anesthetized rats: changes in mean arterial pressure and renal cortical tissue oxygen tension. Crit. Care Med. 24: 1869-1873.
9. Sakai, H., Takeoka, S., Park, S.I., Kose, T., Nishide, H., Izumi, Y., Yoshizu, A., Kobayashi, K., Tsuchida, E. (1997). Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats. Bioconjug. Chem. 8: 23-30.
10. Sakai, H., Horinouchi, H., Tomiyama, K., Ikeda, E., Takeoka, S., Kobayashi, K., Tsuchida, E. (2001). Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system. Am. J. Pathol. 159: 1079-1088.
11. Sakai, H., Takeoka, S., Wettstein, R., Tsai, A.G., Intaglietta, M., Tsuchida, E. (2002). Systemic and microvascular responses to hemorrhagic shock and resuscitation with Hb vesicles. Am. J. Physiol. Heart Circ. Physiol. 283: H1191-1199.
12. Rand, M.L., Leung, R., Packham, M.A. (2003). Platelet function assays. Transfus Apheresis Sci. 28: 307-317.
13. Klinger, M.H. (1997). Platelets and inflammation. Anat. Embryol. (Berl). 196: 1-11.
14. Sou, K., Naito, Y., Endo, T., Takeoka, S., Tsuchida, E. (2003). Effective encapsulation of proteins into size-controlled phospholipid vesicles using freeze-thawing and extrusion. Biotechnol. Prog. 19: 1547-1552.
15. Hagberg, I.A., Lyberg, T. (2000). Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies. Platelets 11: 137-150.
16. Kohmura, C., Hayashi, Y., Ikeda, H. (1999). Detection of activated platelets by flow cytometry. Rinsho Byori 47: 441-452.
17. Santos, M.T., Valles, J., Marcus, A.J., Safier, L.B., Broekman, M.J., Islam, N., Ullman, H.L., Eiroa, A.M., Aznar, J. (1991). Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J. Clin. Invest. 87: 571-580.
18. Hynes, R.O. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
19. Shattil, S.J., Hoxie, J.A., Cunningham, M., Brass, L.F. (1985). Changes in the platelet membrane glycoprotein IIb: IIIa complex during platelet activation. J. Biol. Chem. 260: 11107-11114.
20. Samuelsson, B., Goldyne, M., Granstrom, E., Hamberg, M., Hammarstrom, S., Malmsten, C. (1978). Prostaglandins and thromboxanes. Annu. Rev. Biochem. 47: 997-1029.
21. Ruggeri, Z.M. (2002). Platelets in atherothrombosis. Nat. Med. 8: 1227-1234.
22. Merten, M., Thiagarajan, P. (2000). P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 102: 1931-1936.
23. Stenberg, P.E., McEver, R.P., Shuman, M.A., Jacques, Y.V., Bainton, D.F. (1985). A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J. Cell. Biol. 101: 880-886.
24. Palabrica, T., Lobb, R., Furie, B.C., Aronovitz, M., Benjamin, C., Hsu, Y.M., Sajer, S.A., Furie, B. (1992). Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359: 848-851.
25. Schmidtke, D.W., Diamond, S.L. (2000). Direct observation of membrane tethers formed during neutrophil attachment to platelets or P-selectin under physiological flow. J. Cell. Biol. 149: 719-730.
26. Baggiolini, M., Dahinden, C.A. (1994). CC chemokines in allergic inflammation. Immunol. Today 15: 127-133.
27. Brandt, E., Ludwig, A., Petersen, F., Flad, H.D. (2000). Platelet-derived CXC chemokines: old players in new games. Immunol. Rev. 177: 204-216.